Medicine and Dentistry
Adjuvant Therapy
10%
Biopsy Technique
87%
Bladder
12%
Bleeding
12%
Cancer
16%
Cancer Diagnosis
16%
Cancer Specific Survival
26%
Clear Cell Renal Cell Carcinoma
74%
Clinical Stage
14%
Comorbidity
15%
Cost-Effectiveness Analysis
16%
Cystectomy
22%
Diseases
38%
Enucleation
17%
Germinoma
17%
Hazard Ratio
14%
Health Care Cost
28%
Kidney Cancer
24%
Kidney Tumour
100%
Logistic Regression Analysis
20%
Magnetic Resonance Imaging
65%
Malignant Neoplasm
38%
Meta-Analysis
25%
Multiparametric Magnetic Resonance Imaging
20%
Neoadjuvant Chemotherapy
13%
Neoplasm
67%
Nephrectomy
14%
Odds Ratio
17%
Overall Survival
26%
Partial Nephrectomy
71%
Pediatrics
10%
Proportional Hazards Model
11%
Prostate Biopsy
29%
Prostate Cancer
99%
Prostate Specific Antigen
19%
Prostatectomy
64%
Quality of Life
13%
Radiation Therapy
11%
Radical Nephrectomy
43%
Recurrent Disease
14%
Retroperitoneal Lymph Node Dissection
22%
Robot-Assisted Prostatectomy
23%
Seminoma
20%
Surgeon
17%
Surveillance, Epidemiology, and End Results
11%
Systematic Review
53%
Transitional Cell Carcinoma
14%
Urinary System
12%
Urologic Surgery
25%
Urologist
20%
Keyphrases
Active Surveillance
78%
Cancer-specific Survival
27%
Chemotherapy
12%
Clinically Significant Prostate Cancer
20%
Comorbidity
13%
Confidence Interval
20%
Data Systems
12%
Delayed Intervention
16%
Grade Group
16%
Hazard Ratio
16%
High Risk
12%
Kidney Cancer
18%
Length of Stay
12%
Localized Kidney Cancer
23%
Localized Renal Cell Carcinoma
13%
Low Risk
18%
Magnetic Resonance Imaging
30%
Meta-analysis
25%
Metastatic Renal Cell Carcinoma (mRCC)
14%
Multiparametric MRI (mpMRI)
42%
Muscle-invasive Bladder Cancer
13%
Neoadjuvant Chemotherapy
13%
Odds Ratio
17%
Oncological Outcomes
12%
Opioid Prescribing
14%
Overall Survival
24%
Partial Nephrectomy
52%
Patient Selection
13%
Postoperative Outcomes
23%
Prospective Cohort Study
13%
Prostate
15%
Prostate Biopsy
13%
Prostate Cancer
52%
Prostate Cancer Risk
12%
Prostate Cancer Screening
18%
Radical Cystectomy
13%
Radical Nephrectomy
39%
Radical Prostatectomy
71%
Renal Cell Carcinoma
55%
Renal Mass
19%
Risk Factors
13%
Robot-assisted Radical Prostatectomy
15%
Robotic-assisted
14%
Robotics
12%
Small Renal Mass
55%
Systematic Meta-analysis
23%
Tumor
20%
Tumor Enucleation
16%
Urological Surgery
24%
Urologists
17%